Original Research
Assessment of the clinical validity of an adjusted Marsh pharmacokinetic model using an effect-site rate constant (ke0) of 1.21 min-1
Southern African Journal of Anaesthesia and Analgesia | Vol 27, No 2 | a958 |
DOI: https://doi.org/10.36303/SAJAA.2021.27.2.2583
| © 2021 J.F. Coetzee, A. Links, A.I. Levin
| This work is licensed under Other
Submitted: 12 November 2025 | Published: 30 April 2021
Submitted: 12 November 2025 | Published: 30 April 2021
About the author(s)
J.F. Coetzee, Department of Anaesthesiology and Critical Care, Faculty of Medicine and Health Sciences, Stellenbosch University, South AfricaA. Links, Department of Anaesthesiology and Critical Care, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa
A.I. Levin, Department of Anaesthesiology and Critical Care, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa
Full Text:
PDF (632KB)Abstract
Introduction: The first commercially available target-controlled infusion pump, the “Diprifusor”, employed a “Marsh” pharmacokinetic-pharmacodynamic parameter set, and this model (the Diprifusor-Marsh model) is also available in several of today’s pumps. However, it is unsuited for effect-site, target-controlled infusions (Ce-TCI) because it assumes slow transfer between blood and the effect-site (ke0 = 0.26 min-1). We hypothesised that a faster ke0 of 1.21 min-1 (Adjusted-Marsh model) for Ce-TCI would result in hypnotic effects equivalent to that of the Schnider parameter set (Schnider model).
Methods: We replicated a previously published study that demonstrated the Diprifusor-Marsh model’s unsuitability for Ce-TCI. We randomised 40 unpremedicated young adults into two groups to receive Ce-TCI, employing either the Schnider model or the Adjusted-Marsh model. We infused propofol at 3 000 mg.hour-1, while running a pharmacokinetic simulation and recording the electroencephalographic bispectral index (BIS) electronically. At loss of consciousness (LOC), indicated by a syringe-drop, we converted the infusion to C e-TCI, targeting the effect-site concentration (Ce) observed at LOC, for 20 minutes. We regarded a difference of 10 BIS-units as clinically important.
Results: There were no statistically significant differences between the group medians regarding time-to-LOC, induction-dose, BIS at LOC and C e-target. BIS decreased monotonically in both groups from a median of 78.5 at LOC to a steady-state median (25–27) at 15 minutes. The BIS of the Adjusted-Marsh model group closely followed the BIS of the Schnider model group. At steady state, the median BIS difference (95% CI) was -0.3 (-5.7 to 5.3), which was within the predefined interval for declaring equivalence. The Schnider model group’s mean BIS at steady state did not differ from that of the previous study’s Schnider model group.
Conclusion: Reasons for the progressive BIS decrease to lower than expected values include delayed response-times by the BIS monitor, Ce overshoot explained by front-end kinetics, neural inertia and the choice of surrogate LOC indicator. We conclude that C e-TCI using the Adjusted-Marsh parameter set results in equivalent hypnotic effects to those of the Schnider model, with the proviso that this may apply only to young adults of normal body habitus.
Methods: We replicated a previously published study that demonstrated the Diprifusor-Marsh model’s unsuitability for Ce-TCI. We randomised 40 unpremedicated young adults into two groups to receive Ce-TCI, employing either the Schnider model or the Adjusted-Marsh model. We infused propofol at 3 000 mg.hour-1, while running a pharmacokinetic simulation and recording the electroencephalographic bispectral index (BIS) electronically. At loss of consciousness (LOC), indicated by a syringe-drop, we converted the infusion to C e-TCI, targeting the effect-site concentration (Ce) observed at LOC, for 20 minutes. We regarded a difference of 10 BIS-units as clinically important.
Results: There were no statistically significant differences between the group medians regarding time-to-LOC, induction-dose, BIS at LOC and C e-target. BIS decreased monotonically in both groups from a median of 78.5 at LOC to a steady-state median (25–27) at 15 minutes. The BIS of the Adjusted-Marsh model group closely followed the BIS of the Schnider model group. At steady state, the median BIS difference (95% CI) was -0.3 (-5.7 to 5.3), which was within the predefined interval for declaring equivalence. The Schnider model group’s mean BIS at steady state did not differ from that of the previous study’s Schnider model group.
Conclusion: Reasons for the progressive BIS decrease to lower than expected values include delayed response-times by the BIS monitor, Ce overshoot explained by front-end kinetics, neural inertia and the choice of surrogate LOC indicator. We conclude that C e-TCI using the Adjusted-Marsh parameter set results in equivalent hypnotic effects to those of the Schnider model, with the proviso that this may apply only to young adults of normal body habitus.
Keywords
propofol; drug delivery systems; pharmacokinetic model; pharmacodynamics; bispectral index monitor
Metrics
Total abstract views: 67Total article views: 19
Crossref Citations
1. Stability of BIS with Schnider or modified Marsh effect-site targeted infusions : as you like it, or much ado about nothing?
E. Coetzee, A.R. Absalom
Southern African Journal of Anaesthesia and Analgesia vol: 27 issue: 2 first page: 64 year: 2021
doi: 10.36303/SAJAA.2021.27.2.2617
2. Target-Controlled Infusion of Propofol: A Systematic Review of Recent Results
Pavla Šafránková, Jan Bruthans
Journal of Medical Systems vol: 49 issue: 1 year: 2025
doi: 10.1007/s10916-025-02187-y
